Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Retlirafusp alfa | 2395839-91-3 | Details |
| Lirentelimab | 2283348-97-8 | Details |
| Zanolimumab | 652153-01-0 | Details |
| 2,2-Dimethyl-4,6-dioxo-1,3-dioxane-5-carbaldehyde | C7H8O5 | 72793-38-5 | Details |
| Roledumab | 1174008-79-7 | Details |
| Lodelcizumab | 1355338-54-3 | Details |
| Ulocuplumab | 1375830-34-4 | Details |
| Zelminemab | 2225850-33-7 | Details |
| Tesnatilimab | 2242758-08-1 | Details |
| Letaplimab | 2283356-07-8 | Details |
| Tarperprumig | 2630946-41-5 | Details |
| Linavonkibart | 2640981-30-0 | Details |
| (S)-Viloxazine Hydrochloride | C13H20ClNO3 | 56287-61-7 | Details |
| Vorsetuzumab Mafodotin | 1165741-01-4 | Details |
| Lenzilumab | 1229575-09-0 | Details |
| Tinurilimab | 2226224-30-0 | Details |
| Upifitamab | 2254118-43-7 | Details |
| Zeluvalimab | 2315361-37-4 | Details |
| Enlimomab | 142864-19-5 | Details |
| Simaravibart | 2657609-23-7 | Details |
| Zinlirvimab | 2417213-75-1 | Details |
| Zalutumumab | 667901-13-5 | Details |
| Tarextumab | 1359940-55-8 | Details |
| Recaticimab | 2361290-85-7 | Details |
| Vixtimotamab | 2243775-32-6 | Details |
| Tagitanlimab | 2417649-97-7 | Details |
| NDI-034858 | C23H24N8O3 | 2272904-53-5 | Details |
| Riltovetbart | 2641479-65-2 | Details |
| Litifilimab | 2407378-48-5 | Details |
| Thermospermine | C10H26N4 | 70862-11-2 | Details |
| 3-(Benzo[d]thiazol-2-yl)-7-methoxy-2H-chromen-2-one | C17H11NO3S | 109601-85-6 | Details |
| Pinatuzumab Vedotin | 1313706-14-7 | Details |
| Vadastuximab Talirine | 1436390-64-5 | Details |
| Ziltivekimab | 2226654-05-1 | Details |
| Rozipafusp alfa | 2143449-47-0 | Details |
| Tozorakimab | 2376858-66-9 | Details |
| Licaminlimab | 1688648-13-6 | Details |
| Zimberelimab | 2259860-24-5 | Details |
| Linvoseltamab | 2408319-25-3 | Details |
| 3-(1,3-Dioxolan-2-yl)phenol | C9H10O3 | 7070-85-1 | Details |
| Tenatumomab | 1412891-40-7 | Details |
| Vibostolimab | 2231305-30-7 | Details |
| Teplizumab | 876387-05-2 | Details |
| Valanafusp Alfa | 1815583-32-4 | Details |
| Sudubrilimab | 2387417-06-1 | Details |
| Tarlatamab | 2307488-83-9 | Details |
| Latozinemab | 2376132-27-1 | Details |
| Unasnemab | 2379805-59-9 | Details |
| Sotrovimab | 2423014-07-5 | Details |
| Latikafusp | 2552814-07-8 | Details |
| Simtuzumab | 1318075-13-6 | Details |
| Tildrakizumab | 1326244-10-3 | Details |
| Tisotumab Vedotin | 1418731-10-8 | Details |
| Rosmantuzumab | 1684393-04-1 | Details |
| Tafolecimab | 2225109-03-3 | Details |
| Telazorlimab | 2126777-87-3 | Details |
| Torudokimab | 2241728-76-5 | Details |
| Tamgiblimab | Details |
| SG-094 | C30H29NO3 | Details |
| Rilvegostomig | 2640305-01-5 | Details |
| Lomvastomig | 2648840-52-0 | Details |
| (R)-Viloxazine Hydrochloride | C13H20ClNO3 | 56287-63-9 | Details |
| Atomoxetine EP impurity A | C16H19NO | 56161-70-7 | Details |
| Guselkumab | 1350289-85-8 | Details |
| Tosatoxumab | 1374419-41-6 | Details |
| Vofatamab | 1312305-12-6 | Details |
| Vibecotamab | 2138442-13-2 | Details |
| Sabatolimab | 2252262-24-9 | Details |
| Lonigutamab | 2362015-67-4 | Details |
| Reozalimab | 2445259-99-2 | Details |
| Lipustobart | 2639481-06-2 | Details |
| 5-Amino-2-chloroisonicotinaldehyde | C6H5ClN2O | 1060804-23-0 | Details |
| Seribantumab | 1334296-12-6 | Details |
| Setoxaximab | 1351470-17-1 | Details |
| Sofituzumab Vedotin | 1418200-58-4 | Details |
| Loncastuximab Tesirine | 1879918-31-6 | Details |
| Actinium (225Ac) Lintuzumab Satetraxetan | 2209911-94-2 | Details |
| Sugemalimab | 2256084-03-2 | Details |
| Vulinacimab | 2250342-36-8 | Details |
| Simlukafusp alfa | 1776942-10-9 | Details |
| Zuberitamab | 2251143-19-6 | Details |
| Suciraslimab | 2415439-63-1 | Details |
| Lesabelimab | 2475402-56-1 | Details |
| Varlilumab | 1393344-72-3 | Details |
| 3-(Difluoromethyl)-4-nitro-1H-pyrazole | C4H3F2N3O2 | 1789048-54-9 | Details |
| Vorsetuzumab | 1165740-62-4 | Details |
| Vantictumab | 1345009-45-1 | Details |
| Retifanlimab | 2079108-44-2 | Details |
| Tilvestamab | 2226775-26-2 | Details |
| Tilogotamab | 2109731-10-2 | Details |
| Lecanemab | 1260393-98-3 | Details |
| Rosopatamab | 2260767-49-3 | Details |
| 7-Methoxy-2-oxo-2H-chromene-3-carbohydrazide | C11H10N2O4 | 2514744-75-1 | Details |
| (3R,5'S)-2-oxospiro[indoline-3,3'-pyrrolidine]-5'-carboxamide hydrochloride | C12H14ClN3O2 | 2769953-37-7 | Details |
| Regdanvimab | 2444308-95-4 | Details |
| Rosnilimab | 2412764-40-8 | Details |
| 2-Hydroxycyclohexanone | C6H10O2 | 533-60-8 | Details |
| Namilumab | 1206681-39-1 | Details |
| Serplulimab | 2231029-82-4 | Details |
| Talquetamab | 2226212-40-2 | Details |
| Product Total： Product Page： | ||||
| 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||